Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
Croatia Pharmaceuticals and Healthcare Report Q4 2008 (Business Monitor International)
- Market: Healthcare and Medical
- Report Title: Croatia Pharmaceuticals and Healthcare Report Q4 2008
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Croatia
- Number of Pages: 64
Executive Summary .........5
Croatia Pharmaceuticals Industry SWOT.............................. 6
Croatia Political SWOT......................................................... 7
Croatia Economic SWOT....................................................... 8
Croatia Business Environment SWOT ................................... 9
Pharmaceutical Business Environment Ratings ....................................................10
Table: Central And Eastern Europe Pharmaceutical Business Environment Rankings For Q408 ...................................................................... 10
Limits Of Potential Returns.................................................. 10
Risks To Realisation Of Returns .......................................... 11
Croatia – Market Summary ..................................................13
Regulatory Regime.........14
Table: Croatian Product Approvals, 2006........................... 15
Intellectual Property Regime ............................................... 15
Pricing Regime .................................................................... 17
Reimbursement Regime........................................................ 17
Recent Pricing And Reimbursement Developments ............. 18
Table: Recently Approved Medicines In Croatia ................. 18
Industry Trends And Developments ..........................................................20
Epidemiology....................................................................... 20
Table: Leading Causes Of Death In Croatia, 2005.............. 20
Healthcare Provision........................................................... 21
Healthcare Expenditure ....................................................... 21
Healthcare Debts ................................................................. 22
Healthcare Reforms ............................................................. 23
Domestic Pharmaceutical Industry...................................... 24
Domestic Company Activity................................................. 25
Foreign Company Activities................................................. 25
Table: Lukaps’ Time Line .................................................... 26
Pharmaceutical Retail ......................................................... 26
Research And Development Sector ...................................... 27
Medical Devices................................................................... 28
Industry Forecast Scenario ..................................................30
Overall Market Forecast...................................................... 30
Table: Croatia - Drug Expenditure And Prescription Market Indicators, 2004-2012 (HRKmn unless otherwise stated).................................... 31
Key Growth Factors – Industry............................................ 32
Table: Croatia - Health Expenditure Indicators, 2004-2012 (HRKmn unless otherwise stated).......................................................................... 33
Key Growth Factors – Macroeconomic ............................... 34
Table: Croatia - Economic Activity ..................................... 36
Prescription Market Forecast.............................................. 37
Table: Croatia - Prescription Market Indicators, 2004-2012 (HRKmn unless otherwise stated)......................................................................... 38
OTC Market Forecast.......................................................... 39
Table: Croatia – OTC Market Indicators, 2004-2012 (HRKmn unless otherwise stated).................................................................................... 40
Patented Market Forecast.................................................... 41
Table: Croatia – Patented Market Indicators, 2004-2012 (HRKmn unless otherwise stated) ............................................................................. 41
Generics Market Forecast ................................................... 42
Table: Croatia – Generics Market Indicators, 2004-2012 (HRKmn unless otherwise stated) ............................................................................. 42
Export/Import Forecasts ...................................................... 43
Table: Croatia – Pharmaceutical Trade Indicators, 2004-2012 (HRKmn unless otherwise stated) .................................................................... 44
Other Healthcare Forecasts................................................. 45
Table: Croatia – Other Healthcare Indicators, 2004-2012 (HRKmn unless otherwise stated) ............................................................................ 45
Key Risks To BMI’s Forecast Scenario................................ 46
Competitive Landscape...................................................47
Company Monitor...........48
International Company Profiles................................................ 48
GlaxoSmithKline.................................................................. 48
Pfizer ................................................................................... 49
Sanofi-Aventis...................................................................... 50
Novartis ............................................................................... 51
Merck & Co ......................................................................... 52
Krka..................................................................................... 53
Indigenous Company Profiles ................................................... 54
Pliva ........................................Error! Bookmark not defined.
Belupo.................................................................................. 57
BMI Forecast Modelling ...................................................60
How We Generate Our Pharmaceutical Industry Forecasts ..... 60
Pharmaceutical Business Environment Ratings Methodology .. 61
Ratings Overview................................................................. 61
Table: Pharmaceutical Business Environment Indicators ... 62
Weighting............................................................................. 63
Table: Weighting Of Components ........................................ 63
Sources ..................................................................................... 63
Croatia Pharmaceuticals Industry SWOT.............................. 6
Croatia Political SWOT......................................................... 7
Croatia Economic SWOT....................................................... 8
Croatia Business Environment SWOT ................................... 9
Pharmaceutical Business Environment Ratings ....................................................10
Table: Central And Eastern Europe Pharmaceutical Business Environment Rankings For Q408 ...................................................................... 10
Limits Of Potential Returns.................................................. 10
Risks To Realisation Of Returns .......................................... 11
Croatia – Market Summary ..................................................13
Regulatory Regime.........14
Table: Croatian Product Approvals, 2006........................... 15
Intellectual Property Regime ............................................... 15
Pricing Regime .................................................................... 17
Reimbursement Regime........................................................ 17
Recent Pricing And Reimbursement Developments ............. 18
Table: Recently Approved Medicines In Croatia ................. 18
Industry Trends And Developments ..........................................................20
Epidemiology....................................................................... 20
Table: Leading Causes Of Death In Croatia, 2005.............. 20
Healthcare Provision........................................................... 21
Healthcare Expenditure ....................................................... 21
Healthcare Debts ................................................................. 22
Healthcare Reforms ............................................................. 23
Domestic Pharmaceutical Industry...................................... 24
Domestic Company Activity................................................. 25
Foreign Company Activities................................................. 25
Table: Lukaps’ Time Line .................................................... 26
Pharmaceutical Retail ......................................................... 26
Research And Development Sector ...................................... 27
Medical Devices................................................................... 28
Industry Forecast Scenario ..................................................30
Overall Market Forecast...................................................... 30
Table: Croatia - Drug Expenditure And Prescription Market Indicators, 2004-2012 (HRKmn unless otherwise stated).................................... 31
Key Growth Factors – Industry............................................ 32
Table: Croatia - Health Expenditure Indicators, 2004-2012 (HRKmn unless otherwise stated).......................................................................... 33
Key Growth Factors – Macroeconomic ............................... 34
Table: Croatia - Economic Activity ..................................... 36
Prescription Market Forecast.............................................. 37
Table: Croatia - Prescription Market Indicators, 2004-2012 (HRKmn unless otherwise stated)......................................................................... 38
OTC Market Forecast.......................................................... 39
Table: Croatia – OTC Market Indicators, 2004-2012 (HRKmn unless otherwise stated).................................................................................... 40
Patented Market Forecast.................................................... 41
Table: Croatia – Patented Market Indicators, 2004-2012 (HRKmn unless otherwise stated) ............................................................................. 41
Generics Market Forecast ................................................... 42
Table: Croatia – Generics Market Indicators, 2004-2012 (HRKmn unless otherwise stated) ............................................................................. 42
Export/Import Forecasts ...................................................... 43
Table: Croatia – Pharmaceutical Trade Indicators, 2004-2012 (HRKmn unless otherwise stated) .................................................................... 44
Other Healthcare Forecasts................................................. 45
Table: Croatia – Other Healthcare Indicators, 2004-2012 (HRKmn unless otherwise stated) ............................................................................ 45
Key Risks To BMI’s Forecast Scenario................................ 46
Competitive Landscape...................................................47
Company Monitor...........48
International Company Profiles................................................ 48
GlaxoSmithKline.................................................................. 48
Pfizer ................................................................................... 49
Sanofi-Aventis...................................................................... 50
Novartis ............................................................................... 51
Merck & Co ......................................................................... 52
Krka..................................................................................... 53
Indigenous Company Profiles ................................................... 54
Pliva ........................................Error! Bookmark not defined.
Belupo.................................................................................. 57
BMI Forecast Modelling ...................................................60
How We Generate Our Pharmaceutical Industry Forecasts ..... 60
Pharmaceutical Business Environment Ratings Methodology .. 61
Ratings Overview................................................................. 61
Table: Pharmaceutical Business Environment Indicators ... 62
Weighting............................................................................. 63
Table: Weighting Of Components ........................................ 63
Sources ..................................................................................... 63
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
